Abstract:Abstract Introduction: Lung cancer is the second most common cancer and the leading cause of cancer death in the US and worldwide. The National Lung Screening Trial (NLST) through thoracic low-dose computed tomography (LDCT) scans has shown that screening decreases mortality by 20%, but nearly 40% of patients in the NLST had a positive screen at one point, with 96.4% of these being false positive. It is urgent to develop new non-invasive methods with high efficacy, such as blood molecular biomarkers as companion diagnostic tools to complement LDCT screening. Recent studies have shown that small non-coding RNAs (ncRNAs) play important roles in cancer development, and exosomes are actively secreted extracellular vesicles that contain proteins, lipids, and nucleic acids, including miRNAs and other classes of small ncRNAs. Our study aimed to screen and identify noval plasma exosomal small ncRNAs for lung cancer early detection. Methods: A supersensitive human plasma exosome isolation and purification as well as exosome small RNA sequencing were conducted on 233 human subjects including 117 lung cancer early-stage patients and 116 non-cancer subjects (54 benign and 62 normal samples). Sequencing reads were first processed by trimming off the adapters and low-quality bases using cutadapt. Following trimming, the sequences were aligned to the human genome (Genome Reference Consortium GRCh38) and mapped to different small ncRNA databases using STAR. Read counts for each RNA category (miRNA, piRNA, snRNA, snoRNA, tRNA, tsRNA) were calculated from the mapping results. Differential gene expression analysis was performed by the DESeq2 bioconductor package. The genes with Benjamini and Hochberg q-value < 0.05 were called differentially expressed. Based on the differential gene lists, diagnostic models were built by 10-fold cross validated Least Absolute Shrinkage and Selection Operator (LASSO) logistic regression. Results: A total of 5470 small ncRNAs were initially identified, including 1094 miRNA, 2172 piRNA, 1185 snRNA, 376 snoRNA, 582 tRNA, 61 tsRNA. Using DESeq2 with an FDR q-value < 0.05 with a cut off of 1.5-fold change, we found 508 small ncRNAs significantly differentially expressed between cancer and non-cancer groups, consisting of 231 small ncRNAs up-regulated and 277 down-regulated in tumor. By diagnostic modeling, a set of 16 small ncRNAs were identified as promising biomarkers, which could differentiate patients with cancer from non-cancer with an area under the receiver operating (ROC) curve (AUC) of 96.71%. Using the same sixteen-smallRNA signature to distinguish cancer from benign, the AUC achieved 97.23%; while the same panel could distinguish cancer from normal with an AUC of 96.26%. Conclusion: This preliminary study demonstrated the potential diagnostic value of the exosomal small ncRNA biomarkers in lung cancer early detection. The results will be evaluated by more cases in the future study. Citation Format: Yuanyuan Fu, Masaki Nasu, Mayumi Jijiwa, Yu Chen, Zitong Gao, Isam Ibrahim, Youping Deng. Identifying plasma exosomal small non-coding RNAs as potential biomarkers for lung cancer early detection [abstract]. In: Proceedings of the American Association for Cancer Research Annual Meeting 2023; Part 1 (Regular and Invited Abstracts); 2023 Apr 14-19; Orlando, FL. Philadelphia (PA): AACR; Cancer Res 2023;83(7_Suppl):Abstract nr 867.

Evaluation of EpCAM-specific Exosomal Lncrnas As Potential Diagnostic Biomarkers for Lung Cancer Using Droplet Digital PCR.

Exosomal LncRNA RP5-977B1 as a novel minimally invasive biomarker for diagnosis and prognosis in non-small cell lung cancer

PLA2G10 Incorporated in Exosomes Could Be Diagnostic and Prognostic Biomarker for Non-Small Cell Lung Cancer

Elevated Expression of Exosomal Microrna-21 As a Potential Biomarker for the Early Diagnosis of Pancreatic Cancer Using a Tethered Cationic Lipoplex Nanoparticle Biochip.

Diagnostic Potential Of Serum Exosomal Colorectal Neoplasia Differentially Expressed Long Non-Coding Rna (Crnde-P) And Microrna-217 Expression In Colorectal Carcinoma

Evaluation of Serum Exosomal lncRNAs as Diagnostic and Prognostic Biomarkers for Esophageal Squamous Cell Carcinoma.

Abstract 867: Identifying plasma exosomal small non-coding RNAs as potential biomarkers for lung cancer early detection

Plasma exosomes contain protein biomarkers valuable for the diagnosis of lung cancer

Polymorphisms of EpCAM gene and prognosis for non-small-cell lung cancer in Han Chinese

CLO19-060: Blood Exosomal Long RNA Profiling Identifies Diagnostic and Prognostic Markers in Pancreatic Ductal Adenocarcinoma

Serum exosomal hsa_circ_0069313 has a potential to diagnose more aggressive non-small cell lung cancer

A Circulating Exosome RNA Signature Is a Potential Diagnostic Marker for Pancreatic Cancer, a Systematic Study

Identification of hsa-miR-619-5p and hsa-miR-4454 in plasma-derived exosomes as a potential biomarker for lung adenocarcinoma.

Exosomal LncRNAs and CircRNAs in lung cancer: Emerging regulators and potential therapeutic targets

Integrated plasma and exosome long noncoding RNA profiling is promising for diagnosing non-small cell lung cancer

The diagnostic value of serum exosomal miRNA-587 combined with hypersensitive C-reactive protein as noninvasive biomarker in early-stage non-small cell lung cancer

Exosomal Proteins and Lipids as Potential Biomarkers for Lung Cancer Diagnosis, Prognosis, and Treatment

Circulating Serum Exosomal Long Non-Coding RNAs FOXD2-AS1, NRIR, and XLOC_009459 As Diagnostic Biomarkers for Colorectal Cancer.

Potential of Blood Exosomal ENAH, SEPT9, EGF, MMP-9 and CXCL8 for the Early Screening of Breast Cancer.

Circulating Long RNAs in Serum Extracellular Vesicles: Their Characterization and Potential Application As Biomarkers for Diagnosis of Colorectal Cancer.

Plasma-derived exosomal long noncoding RNAs of pancreatic cancer patients as novel blood-based biomarkers of disease